Infinata’s BioPharm Insight Releases its Catalyst Monitor for March…
Key catalysts include US approval decisions for Zogenix, Biogen Idec, and Johnson & Johnson.
(PRWeb February 26, 2013)
Read the full story at http://www.prweb.com/releases/2013/2/prweb10466568.htm
Comments are closed.